483 Zhejiang Huahai Pharmaceutical Jul 2016

483 Zhejiang Huahai Pharmaceutical Jul 2016

Peter Baker FDA$119.00 - Available Now

FDA investigators audited the Zhejiang Huahai Pharmaceutical - Taizhou, China facility and issued 2 inspectional observations (via FDA 483) on 13 Jul 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 13 Jul 2016
  • Location: Taizhou, China
  • FEI: 3003999190
Add To Cart